IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia
BackgroundRecurrent genetic alterations contributing to leukemogenesis have been identified in pediatric B-cell Acute Lymphoblastic Leukemia (B-ALL), and some are useful for refining classification, prognosis, and treatment selection. IKZF1plus is a complex biomarker associated with a poor prognosis...
Full description
Bibliographic Details
| Main Authors: |
Joaquin Garcia-Solorio,
Juan Carlos Núñez-Enriquez,
Marco Jiménez-Olivares,
Janet Flores-Lujano,
Fernanda Flores-Espino,
Carolina Molina-Garay,
Alejandra Cervera,
Diana Casique-Aguirre,
José Gabriel Peñaloza-Gonzalez,
Ma. Del Rocío Baños-Lara,
Ángel García-Soto,
César Alejandro Galván-Díaz,
Alberto Olaya-Vargas,
Hilario Flores Aguilar,
Minerva Mata-Rocha,
Miguel Ángel Garrido-Hernández,
Juan Carlos Solís-Poblano,
Nuria Citlalli Luna-Silva,
Lena Sarahi Cano-Cuapio,
Pierre Mitchel Aristil-Chery,
Fernando Herrera-Quezada,
Karol Carrillo-Sanchez,
Anallely Muñoz-Rivas,
Luis Leonardo Flores-Lagunes,
Elvia Cristina Mendoza-Caamal,
Beatriz Eugenia Villegas-Torres,
Vincent González-Osnaya,
Elva Jiménez-Hernández,
José Refugio Torres-Nava,
Jorge Alfonso Martín-Trejo,
María de Lourdes Gutiérrez-Rivera,
Rosa Martha Espinosa-Elizondo,
Laura Elizabeth Merino-Pasaye,
María Luisa Pérez-Saldívar,
Silvia Jiménez-Morales,
Everardo Curiel-Quesada,
Haydeé Rosas-Vargas,
Juan Manuel Mejía-Arangure,
Carmen Alaez-Verson |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Frontiers Media S.A.
2024-04-01
|
|---|
| Series: | Frontiers in Oncology
|
|---|
| Subjects: | |
|---|
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1337954/full
|
|---|